Related Experiment Video
Updated: Aug 6, 2026
10:37
Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
Published on: January 16, 2015
Chronic bronchitis--measurements and observations over 10 years
Thorax
|February 1, 1976
Summary
Chronic bronchitis patients faced higher mortality from cardiorespiratory failure and cancer. Smoking cessation and reduced pollution improved sputum volume, but lung function decline persisted with age.
Area of Science:
- Pulmonology
- Respiratory Medicine
- Epidemiology
Background:
- Chronic bronchitis is a significant respiratory condition with long-term health implications.
- Understanding the long-term prognosis and mortality factors in chronic bronchitis patients is crucial for public health.
- Previous studies have indicated a higher mortality rate in individuals with chronic bronchitis.
Purpose of the Study:
- To investigate the long-term mortality and clinical outcomes of patients with chronic bronchitis.
- To identify factors influencing mortality, including cardiorespiratory failure and bronchial carcinoma.
- To assess the impact of environmental factors and treatments on disease progression and lung function.
Main Methods:
- A cohort of 111 chronic bronchitis patients was initially studied in 1963.
- Follow-up examinations including clinical assessment, chest radiography, and pulmonary function tests were conducted in 1974 on 54 surviving patients.
- Mortality data was compared with age- and locality-matched controls.
Main Results:
- The study cohort exhibited significantly higher mortality compared to the general population, primarily due to cardiorespiratory failure and bronchial carcinoma.
- Reductions in cigarette smoking, atmospheric pollution, and antibiotic therapy were associated with decreased 24-hour sputum volume.
- Lower initial one-second forced expiratory volume (FEV1) and vital capacity predicted mortality from cardiorespiratory failure. Continued smoking correlated with a greater decline in the transfer factor (diffusing capacity) for carbon monoxide (TF).
Conclusions:
- Chronic bronchitis is associated with increased mortality, particularly from cardiorespiratory causes and lung cancer.
- While environmental improvements and treatments can alleviate symptoms like sputum volume, they do not halt the age-related decline in lung function (FEV1).
- Smoking cessation remains critical, as it impacts the decline of diffusing capacity (TF).
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...